DGAP-CMS: CompuGroup Medical SE: Release of a capital market information

2018. december 28., péntek, 12:59





DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback


CompuGroup Medical SE: Release of a capital market information


28.12.2018 / 12:59


Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and
Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2
Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No
2016/1052 - 2nd Interim Announcement

CompuGroup Medical SE / Share Buyback


Koblenz, December 28, 2018

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and
Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2
Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No
2016/1052 - 2nd Interim Announcement

In the period from December 21, 2018, up to and including December 27,
2018, CompuGroup Medical SE has bought back a total of 14,777 shares of
CompuGroup Medical SE within the framework of the share buyback program. In
the announcement of December 14, 2018, pursuant to Art. 2 para. 1 of the
Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation
(EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury
shares would commence on December 17, 2018.

The overall volume of the shares bought back daily in the period from
December 21, 2018, up to and including December 27, 2018, and the daily
volume-weighted average stock market prices of the shares are as follows:


























DateOverall volume ofVolume-weighted average

shares bought backstock market price

(number)(EUR, excluding ancillary


costs of purchase, rounded


to four places according to


commercial practice)
December 21, 20187,00039.4549
December 27, 20187,77739.2378
In total:14,77739.3406











The total number of shares which have been bought back so far by CompuGroup
Medical SE since December 17, 2018, up to and including December 27, 2018,
within the framework of the share buyback program thus amounts to 46,077
no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the
Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and
para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is
available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a
bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt
Stock Exchange (Xetra trading).

Koblenz, December 28, 2018

The Management Board

CompuGroup Medical SE

Investor Relations

Maria Trost 21

56070 Koblenz, Germany

T: 49 (0) 261 8000-6200

F: 49 (0) 261 8000-3200














28.12.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de












Language: English
Company: CompuGroup Medical SE

Maria Trost 21

56070 Koblenz

Germany
Internet: www.cgm.com





 
End of News DGAP News Service




762409  28.12.2018 



fncls.ssp?fn=show_t_gif&application_id=762409&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum